NCT04104451View on ClinicalTrials.gov

PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

August 1, 2023

Study Completion Date

August 1, 2023

Conditions

Diabetic Foot Ulcer

Interventions

DRUG

Corlicyte

expanded umbilical cord lining mesenchymal stem cells

Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors

lead

University of Colorado, Denver

OTHER

NCT04104451 - PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS | Biotech Hunter | Biotech Hunter